Transition metal complexes will be used to probe conformational variation
along moderately large DNA molecules, several hundred base pairs in
length. Two specific systems will be investigated: 1. The antitumor drug
cis-diamminedichloroplatinum(II) (Cisplatin) has been shown to bind to
sequences of adjacent guanine bases in a restriction fragment of DNA; this
binding is sensitive to variations in DNA conformation, such that the
sequence d(G6-C-G2) was found not to be a favorable site for platinum
binding except the presence of the intercalator ethidium bromide, a
molecule that modifies DNA structure. This sensitivity of Cisplatin to DNA
conformation will be exploited in two ways. The effect on DNA conformation
of the modified nucleic acid bases inosine and 5-methylcytosine will be
assessed by substituting these bases for G or C in the d(G6-C-G2) sequence
and measuring platinum binding in the presence and absence of ethidium. A
change in DNA conformation caused by incorporation of the modified bases
should lead to increased platinum binding in the absence of ethidium.
Cisplatin binding also will be used as a sensitive reporter of the width of
the major groove of DNA in sequences upstream of eukaryotic genes that show
evidence of being in unusual conformations by virtue of their extreme
nuclease sensitivity. Sequences upstream of the chicken Beta-globin gene,
the histone H-5 gene and the chicken pro-Alpha2(1) gene will be studied.
2. The second experimental system to be studied will be a newly-developed
method for mapping variations of helical twist along DNA molecules of
particular sequence. This technique makes use of the lack of sequence
discrimination shown by the hydroxyl radical in its degradation of the
backbone of DNA, to allow fragmentation of a DNA restriction fragment bound
to a crystalline inorganic surface. A smooth modulation pattern of
fragmentation results from the periodic accessibility to the hydroxyl
radical of the DNA strands bound to the surface. This pattern may be
visualized by separating the products of the fragmentation reaction on a
DNA sequencing gel, and analyzed by densitometry. Hydroxyl radical will be
produced by a reagent consisting of ferrous EDTA, hydrogen peroxide, and
ascorbate. This method will be used to map the helical twist of the
eukaryotic upstream sequences mentioned above. These two experiments will
offer a way of mapping conformation along any DNA molecule, in order to
relate structure to biological activity for DNA.
No Sub Projects information available for 5R01GM040894-08
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01GM040894-08
Patents
No Patents information available for 5R01GM040894-08
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01GM040894-08
Clinical Studies
No Clinical Studies information available for 5R01GM040894-08
News and More
Related News Releases
No news release information available for 5R01GM040894-08
History
No Historical information available for 5R01GM040894-08
Similar Projects
No Similar Projects information available for 5R01GM040894-08